These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 26210742

  • 1. Krüppel-like factor 9 (KLF9) prevents colorectal cancer through inhibition of interferon-related signaling.
    Brown AR, Simmen RC, Raj VR, Van TT, MacLeod SL, Simmen FA.
    Carcinogenesis; 2015 Sep; 36(9):946-55. PubMed ID: 26210742
    [Abstract] [Full Text] [Related]

  • 2. Notch inhibits expression of the Krüppel-like factor 4 tumor suppressor in the intestinal epithelium.
    Ghaleb AM, Aggarwal G, Bialkowska AB, Nandan MO, Yang VW.
    Mol Cancer Res; 2008 Dec; 6(12):1920-7. PubMed ID: 19074836
    [Abstract] [Full Text] [Related]

  • 3. BCL9-2 promotes early stages of intestinal tumor progression.
    Brembeck FH, Wiese M, Zatula N, Grigoryan T, Dai Y, Fritzmann J, Birchmeier W.
    Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
    [Abstract] [Full Text] [Related]

  • 4. Downregulation of Krüppel-like factor 9 in human colorectal cancer.
    Kang L, Lü B, Xu J, Hu H, Lai M.
    Pathol Int; 2008 Jun; 58(6):334-8. PubMed ID: 18477211
    [Abstract] [Full Text] [Related]

  • 5. Haploinsufficiency of Krüppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis.
    Ghaleb AM, McConnell BB, Nandan MO, Katz JP, Kaestner KH, Yang VW.
    Cancer Res; 2007 Aug 01; 67(15):7147-54. PubMed ID: 17671182
    [Abstract] [Full Text] [Related]

  • 6. Krüppel-like factor 5 is a crucial mediator of intestinal tumorigenesis in mice harboring combined ApcMin and KRASV12 mutations.
    Nandan MO, Ghaleb AM, McConnell BB, Patel NV, Robine S, Yang VW.
    Mol Cancer; 2010 Mar 18; 9():63. PubMed ID: 20298593
    [Abstract] [Full Text] [Related]

  • 7. Stromal Indian hedgehog signaling is required for intestinal adenoma formation in mice.
    Büller NV, Rosekrans SL, Metcalfe C, Heijmans J, van Dop WA, Fessler E, Jansen M, Ahn C, Vermeulen JL, Westendorp BF, Robanus-Maandag EC, Offerhaus GJ, Medema JP, D'Haens GR, Wildenberg ME, de Sauvage FJ, Muncan V, van den Brink GR.
    Gastroenterology; 2015 Jan 18; 148(1):170-180.e6. PubMed ID: 25307863
    [Abstract] [Full Text] [Related]

  • 8. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW, Choi H, So D, Kim YI, Cho K, Chung HJ, Lee KH, Chun YS, Cho CH, Kang GH, Kim WH, Park JW.
    Gastroenterology; 2014 Aug 18; 147(2):430-442.e8. PubMed ID: 24846398
    [Abstract] [Full Text] [Related]

  • 9. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
    Li X, Stevens PD, Liu J, Yang H, Wang W, Wang C, Zeng Z, Schmidt MD, Yang M, Lee EY, Gao T.
    Gastroenterology; 2014 May 18; 146(5):1301-12.e1-10. PubMed ID: 24530606
    [Abstract] [Full Text] [Related]

  • 10. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD, Sun GB, Jiao P, Chen C, Liu QF, Huang XL, Zhang R, Cai WY, Li SN, Wu JF, Liu YJ, Wu RS, Xie YY, Chan EC, Liou YC, Li BA.
    Gastroenterology; 2016 Mar 18; 150(3):659-671.e16. PubMed ID: 26619963
    [Abstract] [Full Text] [Related]

  • 11. Haploinsufficiency of Krüppel-like factor 5 rescues the tumor-initiating effect of the Apc(Min) mutation in the intestine.
    McConnell BB, Bialkowska AB, Nandan MO, Ghaleb AM, Gordon FJ, Yang VW.
    Cancer Res; 2009 May 15; 69(10):4125-33. PubMed ID: 19435907
    [Abstract] [Full Text] [Related]

  • 12. Kruppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells.
    Velarde MC, Zeng Z, McQuown JR, Simmen FA, Simmen RC.
    Mol Endocrinol; 2007 Dec 15; 21(12):2988-3001. PubMed ID: 17717078
    [Abstract] [Full Text] [Related]

  • 13. Liver X receptors inhibit proliferation of human colorectal cancer cells and growth of intestinal tumors in mice.
    Lo Sasso G, Bovenga F, Murzilli S, Salvatore L, Di Tullio G, Martelli N, D'Orazio A, Rainaldi S, Vacca M, Mangia A, Palasciano G, Moschetta A.
    Gastroenterology; 2013 Jun 15; 144(7):1497-507, 1507.e1-13. PubMed ID: 23419360
    [Abstract] [Full Text] [Related]

  • 14. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse.
    Paoni NF, Feldman MW, Gutierrez LS, Ploplis VA, Castellino FJ.
    Physiol Genomics; 2003 Nov 11; 15(3):228-35. PubMed ID: 13130079
    [Abstract] [Full Text] [Related]

  • 15. Epithelial-specific deletion of 11β-HSD2 hinders Apcmin/+ mouse tumorigenesis.
    Jiang L, Yang S, Yin H, Fan X, Wang S, Yao B, Pozzi A, Chen X, Harris RC, Zhang MZ.
    Mol Cancer Res; 2013 Sep 11; 11(9):1040-50. PubMed ID: 23741059
    [Abstract] [Full Text] [Related]

  • 16. Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the Apc Min/+ mouse model of intestinal tumorigenesis.
    Hull MA, Cuthbert RJ, Ko CWS, Scott DJ, Cartwright EJ, Hawcroft G, Perry SL, Ingram N, Carr IM, Markham AF, Bonifer C, Coletta PL.
    Sci Rep; 2017 Jul 20; 7(1):6074. PubMed ID: 28729694
    [Abstract] [Full Text] [Related]

  • 17. Constitutive TLR4 signalling in intestinal epithelium reduces tumor load by increasing apoptosis in APC(Min/+) mice.
    Li Y, Teo WL, Low MJ, Meijer L, Sanderson I, Pettersson S, Greicius G.
    Oncogene; 2014 Jan 16; 33(3):369-77. PubMed ID: 23318418
    [Abstract] [Full Text] [Related]

  • 18. Elevated Coexpression of KITENIN and the ErbB4 CYT-2 Isoform Promotes the Transition from Colon Adenoma to Carcinoma Following APC loss.
    Bae JA, Kho DH, Sun EG, Ko YS, Yoon S, Lee KH, Ahn KY, Lee JH, Joo YE, Chung IJ, Lee SH, Kim H, Kim KK.
    Clin Cancer Res; 2016 Mar 01; 22(5):1284-94. PubMed ID: 26527747
    [Abstract] [Full Text] [Related]

  • 19. Serine-threonine Kinase Receptor-Associated Protein is a Critical Mediator of APC Mutation-Induced Intestinal Tumorigenesis Through a Feed-Forward Mechanism.
    Vu T, Datta A, Banister C, Jin L, Yuan G, Samuel T, Bae S, Eltoum IE, Manne U, Zhang B, Welner RS, Mitra K, Buckhaults P, Datta PK.
    Gastroenterology; 2022 Jan 01; 162(1):193-208. PubMed ID: 34520730
    [Abstract] [Full Text] [Related]

  • 20. Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice.
    Musteanu M, Blaas L, Mair M, Schlederer M, Bilban M, Tauber S, Esterbauer H, Mueller M, Casanova E, Kenner L, Poli V, Eferl R.
    Gastroenterology; 2010 Mar 01; 138(3):1003-11.e1-5. PubMed ID: 19962983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.